BD marketing image of its Alaris infusion pump and vital signs monitoring system
BD’s Alaris infusion pump and vital signs monitoring system is designed to deliver controlled amounts of fluid, medication, blood and blood products. [Photo courtesy of BD]

BD (NYSE:BDX) today issued a voluntary notification regarding cybersecurity vulnerabilities with its Alaris Infusion Central software.

Alaris Infusion Central, a standalone software — separate from pumps — provides data from the Alaris pumps. It allows healthcare providers to monitor infusion data sent from Alaris Plus and Alaris neXus pumps on a computer. Alaris Infusion Central is not sold in the U.S. Despite similar product family names, the vulnerability does not impact users of the Alaris PCU 8015 or Alaris Systems Manager.

Get the full story at our sister site, Drug Delivery Business News.